Table 3. Distribution of patients according to the prevalence of comorbidities before and after gastroplasty, operated on at a Public Hospital in the Midwest, from 2011 to 2023, Brazil.

Associated comorbidities	Pre-gastroplasty n (%)	Post-gastroplasty n (%)	p-value	X2
Metabolic Syndrome	157 (49.7)	14(4.4)	<0.001	47.02
Hypertension	157 (49.7)	40 (12.7)	<0.001	53.02
Depression/Anxiety	145(45.9)	98(31.0)	<0.001	40.88
Arthropathy	143(45.3)	22 (7.0)	<0.001	46.01
Diabetes mellitus	137(43.4)	18(5.7)	<0.001	41.02
Sleep Apnea	78 (24.7)	3 (0.9)	0.015	27.04
Esophagitis	89 (34.1)	15(4.2)	<0.001	24.04
Dyslipidemia	95 (30.1)	8 (2.5)	0.001	25.04
Hepatic steatosis	122(38.6)	5(1.6)	0.050	21.05